IGF1 and osteosarcoma: Early experimental studies demonstrated that human osteogenic sarcoma cells were responsive to IGF1 for mitogenesis while reduction in IGF1 levels by hypophysectomy inhibited the aggressive metastatic behavior of osteosarcoma both in vitro and in vivo [137].